Evaluation Of Clostridium Difficile Vaccine Lot Consistency In Healthy Adults 65 To 85 Years Of Age

PHASE3CompletedINTERVENTIONAL
Enrollment

1,317

Participants

Timeline

Start Date

July 31, 2018

Primary Completion Date

August 6, 2019

Study Completion Date

August 6, 2019

Conditions
Clostridium Difficile Associated Disease
Interventions
BIOLOGICAL

Clostridium difficile vaccine

Toxoid based Clostridium difficile vaccine

BIOLOGICAL

placebo

Normal saline solution

Trial Locations (24)

28209

PMG Research of Charlotte, LLC, Charlotte

28401

PMG Research of Wilmington, LLC, Wilmington

29445

Medical Research South, LLC, Goose Creek

30281

Clinical Research Atlanta, Stockbridge

30331

Atlanta Center for Medical Research, Atlanta

32720

Avail Clinical Research, LLC, DeLand

33024

Research Centers of America, LLC, Hollywood

33134

Clinical Research of South Florida, Coral Gables

36608

Coastal Clinical Research, Inc., Mobile

67207

Heartland Research Associates, LLC, Wichita

68134

Meridian Clinical Research, LLC, Omaha

68701

Meridian Clinical Research, LLC, Norfolk

70121

Ochsner Clinic Foundation, New Orleans

73112

Lynn Health Science Institute, Oklahoma City

78229

Diagnostics Research Group, San Antonio

78705

Benchmark Research, Austin

83642

Advanced Clinical Research, Meridian

84020

J. Lewis Research Inc. / Foothill Family Clinic Draper, Draper

84095

J. Lewis Research, Inc. / Jordan River Family Medicine, South Jordan

84109

J. Lewis Research, Inc./ Foothill Family Clinic South, Salt Lake City

84121

J. Lewis Research, Incorporated/Foothill Family Clinic South, Salt Lake City

96001

Paradigm Clinical Research Centers, Inc., Redding

96814

East-West Medical Research Institute, Honolulu

08869

Amici Clinical Research, Raritan

Sponsors

Lead Sponsor

All Listed Sponsors
lead

Pfizer

INDUSTRY

NCT03579459 - Evaluation Of Clostridium Difficile Vaccine Lot Consistency In Healthy Adults 65 To 85 Years Of Age | Biotech Hunter | Biotech Hunter